يحاول ذهب - حر
PlasmaGen secures ₹150 cr to expand into global markets
December 23, 2025
|Mint Chennai
Biopharmaceutical company PlasmaGen Biosciences raised ₹150 crore in a new round of equity financing, valuing the firm at more than ₹1,500 crore.
ViNS Bioproducts, a specialty biopharma company, picked up a minority equity stake in PlasmaGen and led the round with participation from existing investors and other pharma companies and family offices.
PlasmaGen will use the new funds to take its business international. The company has identified distribution partners in “key” export markets.
Back home, the company plans to double down on its presence with its current portfolio of plasma-derived therapeutics. The company’s key products include albumin, intravenous immunoglobulin, rabies immunoglobulin, hepatitis B immunoglobulin, and RhD immunoglobulin (anti-D) which it distributes to private hospitals and state hospitals in India.
هذه القصة من طبعة December 23, 2025 من Mint Chennai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Chennai
Mint Chennai
Dec gold ETFs log record ₹11,647 cr
India’s equity investors are flocking to gold exchange- traded funds as a hedge against stock market volatility amid global headwinds.
1 min
January 10, 2026
Mint Chennai
Relief for Vi as DoT freezes dues at ₹744 cr over 6 years
DoT will do a detailed reassessment of ₹87,695 cr of the firm’s AGR dues in next few months
2 mins
January 10, 2026
Mint Chennai
Merchant banks in Sebi squeeze as new rules kick in
and head of equity capital markets at Equirus Capital.
2 mins
January 10, 2026
Mint Chennai
Better than the real thing
STREAM OF STORIES
3 mins
January 10, 2026
Mint Chennai
How the ASI discovered the ancient site of Keeladi
No archaeological site has been as contested as Keeladi in Tamil Nadu, home to a Sangam-era urban settlement
3 mins
January 10, 2026
Mint Chennai
US trade fears rattle markets; Nifty below 26,000
Domestic equities were shaken by the ‘Trump factor’ throughout the week, leaving India the worst-performing major market globally as risk-off sentiment gripped investors.
1 mins
January 10, 2026
Mint Chennai
India refutes US claim over bilateral deal failure
This marked one of the rare occasions when the Indian side has pushed back against remarks by a senior US official, the other being New Delhi’s rejection of Trump's claims to have brokered a ceasefire to end a brief but intense conflict between India and Pakistan in May 2025.
1 min
January 10, 2026
Mint Chennai
Defunct Udan airports cost govt nearly ₹900 cr
India's plan to connect its interior areas by air has run into heavy weather, with expensive infrastructure and commercial viability playing spoilsport while hundreds of crores are being spent to maintain airports where no planes are landing.
1 min
January 10, 2026
Mint Chennai
‘Dream is to be a one-stop shop for child and mother’
Alia Bhatt and Reliance Retail-backed Ed-A-Mamma has ventured into the kids and baby personal care category, with plans to tap other segments, such as teenage clothing and pet care, the actor-entrepreneur told *Mint* in an interview on Friday.
1 mins
January 10, 2026
Mint Chennai
Drawing on faith and supernatural forces
Amitav Ghosh's latest novel is a page turner, often veering into a realm of magical occurrences, but stretches the reader's beliefs a bit too far
5 mins
January 10, 2026
Listen
Translate
Change font size